CEO's Investment
Outlook
BBHVanEck Biotech ETF
Fund Description
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS®US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
-
Fund Ticker
BBH -
Exchange
NASDAQ -
ETF Structure
Physical -
Administrator
Van Eck Associates -
Custodian
State Street Bank and Trust Company -
Index Ticker
MVBBHTR -
Index Rebalancing
Quarterly
as of 09/20/21
-
30-Day SEC Yield1
0.12% -
Total Net Assets
$614.4M -
Number of Holdings
25 -
Options
Available -
Gross Expense Ratio2
0.39% -
Net Expense Ratio/TER2
0.35% -
Distribution Frequency
Annual
Portfolio Composition (%)
as of 09/17/21
- % of Net Assets
-
Stocks
99.84 -
Bonds
0.00 -
Other
0.00 -
Cash
0.16
Daily Holdings (%) as of 09/17/21 Daily Holdings
Total Holdings: 25
|
Ticker
|
Holding Name |
Identifier (FIGI)
|
Shares | Asset Class |
Market Value (US$) |
% of Net Assets |
|---|---|---|---|---|---|---|
|
MRNA US
|
Moderna Inc |
BBG003PHHZT1
|
172,758
|
Stock | 74,294,578 | 11.87 |
|
AMGN US
|
Amgen Inc |
BBG000BBS2Y0
|
224,343
|
Stock | 49,216,367 | 7.87 |
|
GILD US
|
Gilead Sciences Inc |
BBG000CKGBP2
|
460,946
|
Stock | 33,008,343 | 5.28 |
|
VRTX US
|
Vertex Pharmaceuticals Inc |
BBG000C1S2X2
|
162,766
|
Stock | 30,648,838 | 4.90 |
|
IQV US
|
Iqvia Holdings Inc |
BBG00333FYS2
|
118,929
|
Stock | 30,485,071 | 4.87 |
|
REGN US
|
Regeneron Pharmaceuticals Inc |
BBG000C734W3
|
46,547
|
Stock | 30,343,058 | 4.85 |
|
ILMN US
|
Illumina Inc |
BBG000DSMS70
|
67,274
|
Stock | 30,072,151 | 4.81 |
|
BNTX US
|
Biontech Se |
BBG00Q70B3V1
|
83,374
|
Stock | 29,946,273 | 4.79 |
|
BIIB US
|
Biogen Inc |
BBG000C17X76
|
96,870
|
Stock | 29,079,405 | 4.65 |
|
ICLR US
|
Icon Plc |
BBG000CTSZQ6
|
107,888
|
Stock | 28,940,270 | 4.62 |
|
CRL US
|
Charles River Laboratories Internationa |
BBG000BG5BL8
|
59,564
|
Stock | 26,234,964 | 4.19 |
|
TECH US
|
Bio-Techne Corp |
BBG000C15114
|
48,061
|
Stock | 25,686,532 | 4.11 |
|
SGEN US
|
Seagen Inc |
BBG000BH0FR6
|
148,195
|
Stock | 23,149,541 | 3.70 |
|
NVAX US
|
Novavax Inc |
BBG000NVSBL7
|
91,602
|
Stock | 21,759,139 | 3.48 |
|
BGNE US
|
Beigene Ltd |
BBG00B6WF7T5
|
51,916
|
Stock | 20,929,416 | 3.34 |
|
EXAS US
|
Exact Sciences Corp |
BBG000CWL0F5
|
192,241
|
Stock | 20,790,864 | 3.32 |
|
ALNY US
|
Alnylam Pharmaceuticals Inc |
BBG000BFGNJ5
|
91,113
|
Stock | 17,342,448 | 2.77 |
|
GH US
|
Guardant Health Inc |
BBG006D97VY9
|
129,432
|
Stock | 17,091,496 | 2.73 |
|
QGEN US
|
Qiagen Nv |
BBG000GTYWL7
|
288,486
|
Stock | 15,676,329 | 2.51 |
|
NTRA US
|
Natera Inc |
BBG001J1BQ86
|
115,336
|
Stock | 14,576,772 | 2.33 |
|
INCY US
|
Incyte Corp |
BBG000BNPSQ9
|
165,773
|
Stock | 12,597,090 | 2.01 |
|
BMRN US
|
Biomarin Pharmaceutical Inc |
BBG000CZWZ05
|
146,421
|
Stock | 11,385,697 | 1.82 |
|
CRSP US
|
Crispr Therapeutics Ag |
BBG00DBBGRX1
|
86,411
|
Stock | 10,759,898 | 1.72 |
|
TXG US
|
10x Genomics Inc |
BBG007WX14X0
|
63,672
|
Stock | 10,409,735 | 1.66 |
|
NTLA US
|
Intellia Therapeutics Inc |
BBG007KC7PB0
|
65,728
|
Stock | 10,340,425 | 1.65 |
|
--
|
Other/Cash |
--
|
--
|
Cash | 979,594 | 0.16 |
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.